Latest Breaking News On - Nathalie meetz - Page 1 : comparemela.com

Investegate |F Hoffmann-La Roche Ltd Announcements | F Hoffmann-La Roche Ltd: CHMP recommends expansion of EU label for Hemlibra to include people with moderate haemophilia A

Investegate announcements from F. Hoffmann-La Roche Ltd, CHMP recommends expansion of EU label for Hemlibra to include people with moderate haemophilia A

United statesNathalie meetzLevi garrawayLoren kalmChugai pharmaceutical co ltdInternational society on thrombosisEuropean commissionDrug administrationHead of global product developmentWorld federation of hemophiliaEuropean unionEuropean medicines agencyRoche groupVirtual congressCommittee for medicinal products human useRoche group media relations

Roche launches new diagnostic test for the better understanding of immune response to SARS-CoV-2

Roche launches new diagnostic test for the better understanding of immune response to SARS-CoV-2
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNathalie meetzBirgit masjostThomas schineckerSabine borngrGerard tobinBruno eschliWorld health organizationEuropean unionRoche groupLg chem life sciencesRoche group media relationsLancet glob healthLife sciencesDow jones sustainability indicesChugai pharmaceutical

Roche s Elecsys Amyloid Plasma Panel granted FDA

The Elecsys Amyloid Plasma Panel is intended to be used in conjunction with other clinical information in symptomatic patients who are being evaluated for.

United statesNathalie meetzSileia urechLoren kalmThomas schineckerKarsten kleineWorld alzheimer report reveals disease internationalWorld health organizationDrug administrationAmyloid plasma panelElecsys amyloid plasma panelBreakthrough devices programAlzheimer disease internationalRoche groupDementia world health organizationRoche group media relations

F Hoffmann-La Roche Ltd: Roche launches innovative dual antigen and antibody diagnostic test supporting the fight to eliminate the hepatitis C virus

Elecsys HCV Duo is the first commercially available immunoassay that allows the simultaneous and independent determination of the hepatitis C virus (HCV) antigen and antibody status.The Elecsys HCV Duo

United statesNathalie meetzBirgit masjostLoren kalmThomas schineckerSabine borngrGerard tobinBruno eschliWorld health organizationWorld hepatitis allianceRoche groupRoche group media relationsDow jones sustainability indicesChugai pharmaceutical

F Hoffmann-La Roche Ltd: New two-year data confirm Roche s Vabysmo improves vision with fewer treatments for people with neovascular age-related macular degeneration

In the TENAYA and LUCERNE studies, more than 60% of Vabysmo patients could be treated every four months at two years. This represents an increase from 45% at year one Patients treated with Vabysmo received

United statesUnited kingdomNathalie meetzLevi garrawayBirgit masjostLoren kalmSabine borngrGerard tobinBruno eschliHead of global product developmentBright focus foundationRoche groupEuropean medicines agencyLancet glob healthRoche group media relationsRetina specialists annual scientific meeting